These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Living-Donor Kidney Transplant-Associated Thrombotic Microangiopathy Successfully Treated With Thymoglobulin: A Case Report. Akl A; Alobaidi S; Aboalsamh G Exp Clin Transplant; 2019 Jan; 17(Suppl 1):175-177. PubMed ID: 30777549 [TBL] [Abstract][Full Text] [Related]
6. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients. Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969 [TBL] [Abstract][Full Text] [Related]
7. Thrombotic Microangiopathy in a Pregnant Woman With Kidney Transplantation: A Case Report. Cherniak V; Demir KK; Sandal S; Cantarovich M; Podymow T; Naessens V; Ponette V; Wou K; Do AT; Malhamé I J Obstet Gynaecol Can; 2021 Jul; 43(7):874-878. PubMed ID: 33310162 [TBL] [Abstract][Full Text] [Related]
9. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab. Shochet L; Kanellis J; Simpson I; Ta J; Mulley W Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 Manifesting as Renal Allograft Dysfunction, Acute Pancreatitis, and Thrombotic Microangiopathy: A Case Report. Jespersen Nizamic T; Huang Y; Alnimri M; Cheng M; Chen LX; Jen KY Transplant Proc; 2021 May; 53(4):1211-1214. PubMed ID: 33436168 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors. Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389 [TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor toxicity in de novo thrombotic microangiopathy-Is the culprit what we think it is? Petr V; Zahradka I; Viklicky O Am J Transplant; 2024 Sep; 24(9):1708-1709. PubMed ID: 38677652 [No Abstract] [Full Text] [Related]
13. [Thrombotic microangiopathy following kidney transplantation revealing factors H and I deficiencies]. Fraison JB; Pernin V; Alméras C; Vetromile F; Frémeaux-Bacchi V; Mourad G Rev Med Interne; 2011 Jun; 32(6):e81-3. PubMed ID: 20667630 [TBL] [Abstract][Full Text] [Related]
14. A key step towards setting a benchmark for tackling transplant-associated thrombotic microangiopathy. Scordo M; Giralt SA Br J Haematol; 2020 Jun; 189(6):1006-1009. PubMed ID: 32048273 [No Abstract] [Full Text] [Related]
15. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival. Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601 [TBL] [Abstract][Full Text] [Related]
17. Thrombotic microangiopathy in a kidney transplant patient after COVID‑19. Tarasewicz A; Perkowska-Ptasińska A; Dębska-Ślizień A Pol Arch Intern Med; 2021 Dec; 131(12):. PubMed ID: 34661381 [No Abstract] [Full Text] [Related]
18. Thrombotic microangiopathy involving kidney allograft and peripheral nerves. Naddaf E; James B Dyck P; Said S; Amer H Am J Transplant; 2020 May; 20(5):1454-1456. PubMed ID: 31816173 [TBL] [Abstract][Full Text] [Related]
19. De Novo and Recurrent Thrombotic Microangiopathy After Renal Transplantation: Current Concepts in Management. Abbas F; Abbas SF Exp Clin Transplant; 2022 Jun; 20(6):549-557. PubMed ID: 34546154 [TBL] [Abstract][Full Text] [Related]
20. Thrombotic Microangiopathy in a Transplant Recipient. Mundra VRR; Mannon RB Clin J Am Soc Nephrol; 2018 Aug; 13(8):1251-1253. PubMed ID: 30042222 [No Abstract] [Full Text] [Related] [Next] [New Search]